GLP1R and atherosclerosis: While atherosclerosis and subsequent cardiovascular events sometimes fall into serious and lethal situations, it has been reported recently that the administration of GLP-1 receptor activator leads to the reduction of cardiovascular events and cardiovascular-related death (Table 1) [57,58,59,60,61,62,63,64], in addition to atherosclerosis as described above.